|
Production Plants
Lingolsheim, France
Octapharma SA
70-72 Rue du Maréchal Foch
BP 33
F- 67381 Lingolsheim
FRANCE
In April 1999, Octapharma acquired this production facility in Lingolsheim, near Strasbourg, France. In less than a year, the plant was integrated into Octapharma operations by the transfer of technology for the production of clotting Factors VIII and IX, Immunoglobulins and albumin, using intermediate fractions from the basic fractionation plant in Vienna.
From last quarter of 2001, new equipment had been installed to allow processing of 400,000 litres plasma per year starting with thawing of the plasma pool. This capacity includes the purification of intermediates.
The increase in fractionation capacity was accompanied by enlargement and modernisation of the analytical laboratories and the creation of a state-of-the-art labelling and packaging area.
In 2003 a piece of land adjacent to the Octapharma premises was purchased enabling further extension in the years to come.
In 2005 the planning for rebuilding and construction of a central administration and laboratory building, the cafeteria and the production related personnel facilities was completed and the project initiated.
A production unit for PPSB and FIX concentrates was added 2005/2006 to further increase productivity of the site and strengthen the position of this site as production unit for global self-sufficiency projects.
In 2006 Octapharma completed a production building, which welcomed new personnel facilities for workers and new offices for production and support.
|
|
 |
|
Octapharma will sponsor two satellite symposia at the upcoming ISBT Congress, June 7 - 12, 2008 in Macau SAR, China
May 27, 2008
Octapharma at WFH Congress, June 1 - 5, 2008, Istanbul, Turkey
May 24, 2008
Octapharma acquisition of a plasma fractionation plant in Springe, Germany from German Red Cross organizations
May 8, 2008
|
|
|
|
